Jersey Shore University Medical Center Recognized as GammaTile® Center of Excellence in Patient Care

Expanded Access to Innovative Brain Cancer Treatment

GT Medical Technologies has officially recognized Jersey Shore University Medical Center (JSUMC) as a GammaTile® Center of Excellence. This accolade highlights the institution's outstanding patient care and dedication to advancing treatment for brain tumors. Under this designation, JSUMC joins a select group of healthcare facilities demonstrating exceptional expertise in the GammaTile procedure, aimed at optimizing patient outcomes.

Recognition of Leading Healthcare Professionals

The GammaTile Center of Excellence program is designed to honor institutions and healthcare professionals who excel in the field of brain tumor treatment. Notable figures at JSUMC, including Dr. Shabbar F. Danish, Professor and Chair of the Department of Neurosurgery, and Dr. Nitesh V. Patel, Assistant Professor and Co-Director of Neurosurgical Oncology, have played pivotal roles in meeting the rigorous criteria required for this designation. Their commitment to enhancing clinical skills and patient education is a testament to their leadership in the medical community.

Dr. Danish expressed pride in receiving this honor, stating, "This designation is a powerful acknowledgment of our commitment to advancing brain tumor care. Innovative treatments like GammaTile are changing what's possible for patients and their families—and we're honored to be part of that progress."

Understanding the GammaTile Technology

GammaTile is at the forefront of medical technology, representing a significant leap in how radiation therapy is administered to brain tumor patients. Unlike traditional methods that necessitate waiting periods between surgery and radiation treatment, GammaTile is implanted at the time of tumor removal. This direct placement allows radiation to target cancer cells immediately when they are most vulnerable, thereby maximizing therapeutic effectiveness and minimizing the likelihood of recurrence.

The GammaTile is a bioabsorbable collagen implant embedded with radiation seeds, which are strategically placed in the surgical cavity. This localized treatment approach not only focuses on destroying lingering cancer cells but also reduces exposure to healthy brain tissue, which is crucial for preserving cognitive functions and improving the quality of life for patients.

Since its introduction to the market in March 2020, GammaTile has gained widespread acceptance, with more than 100 medical centers utilizing this advanced treatment. The continued adoption of GammaTile underscores its significance in both academic and community healthcare settings, offering hope and improved care to countless brain tumor patients.

Commitment to Innovation and Excellence

GT Medical Technologies, established by a team of dedicated brain tumor specialists, is constantly striving to meet the unmet needs of patients suffering from brain tumors. The company's mission centers around providing groundbreaking solutions that raise the standard of care. The designation of Jersey Shore University Medical Center as a GammaTile Center of Excellence is another step toward achieving this goal, ensuring patients have access to the most advanced treatment options available.

As GT Medical Technologies looks to the future, they remain committed to innovation in treatment delivery. Their ongoing research and development aim to further refine the use of GammaTile, ensuring even greater efficacy and safety for patients battling brain tumors.

For more information about GammaTile and its impact on brain tumor therapy, visit gammatile.com or follow @GammaTile on social media platforms.

The recognition of Jersey Shore University Medical Center is a significant milestone not only for the institution but also for the broader medical community dedicated to improving brain cancer treatment and patient outcomes. Through initiatives like the GammaTile Center of Excellence program, GT Medical Technologies and its partners are collectively pushing the boundaries of what is possible in medical care, ultimately aiming to transform the lives of patients and their families affected by brain tumors.